Healthcare >> CEO Interviews >> October 5, 2000
DR. NATHANIEL DAVID was primarily responsible for assembling Syrrx, Inc.
and now serves as the company's Director of Business Development. Dr.
David received his AB in Biology and Biochemistry from Harvard College
in 1990 and his PhD in Molecular and Cellular Biology in 1998 from The
University of California, Berkeley. After college, Dr. David joined Cell
Genesys and became one of the first genetic engineers involved in the
Xenomouse project, a technology now marketed by Abgenix. Profile
TWST: Could we start with a history and brief overview of Syrrx, Inc.?Dr. David: Syrrx was founded in the first quarter of 1999. We forged a
strategic alliance with Genomics Institute of the